Share this to:

Support & Insight for the Autumn of Life

June 7, 2020

Coronavirus’ Brain Impact

In some cases, COVID-19 patients may present with neurological symptoms. Having an MRI while at the hospital, as well as monitoring after hospitalization, are important

Read More »
You Might Also Like

Recent Stories

old people's home, dementia

FDA Okays Rexulti for Agitation in Alzheimer’s

The US Food and Drug Administration has announced the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s. Learn more.

Caregivers, Carry On Better

Stress is like a glass of water; we have to put it down for a while and rest before holding it again. Here’s how to do it.

On Trend

Most Popular Stories

old people's home, dementia

FDA Okays Rexulti for Agitation in Alzheimer’s

The US Food and Drug Administration has announced the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s. Learn more.

Caregivers, Carry On Better

Stress is like a glass of water; we have to put it down for a while and rest before holding it again. Here’s how to do it.

Some Diabetes Drugs Cut Alzheimer’s Risk

People taking certain drugs to lower blood sugar for Type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer’s disease, and showed slower cognitive decline than diabetics not taking drugs and people with diabetes. Find out more.

Get The Latest Updates

Subscribe To Our Weekly Newsletter

No spam, only news and updates.

Books

Amazon Books
Amazon Books

Social Media

Categories

New Posts

News to Get at the Truth

Subscribe To Our Weekly Newsletter

Enjoy thought-provoking videos & articles
News to Get at the Truth

Subscribe To Our Weekly Newsletter